Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization

Opsonic defects have been reported in unimmunized patients with sickle cell disease. We found significant increases (P

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 1983, Vol.102 (1), p.51-54
Hauptverfasser: Chudwin, David S., Wara, Diane W., Matthay, Katherine K., Caulfield, Mary H., Schiffman, Gerald, Mentzer, William C., Ammann, Arthur J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 54
container_issue 1
container_start_page 51
container_title The Journal of pediatrics
container_volume 102
creator Chudwin, David S.
Wara, Diane W.
Matthay, Katherine K.
Caulfield, Mary H.
Schiffman, Gerald
Mentzer, William C.
Ammann, Arthur J.
description Opsonic defects have been reported in unimmunized patients with sickle cell disease. We found significant increases (P
doi_str_mv 10.1016/S0022-3476(83)80285-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80349006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022347683802856</els_id><sourcerecordid>80349006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-29893765fd1ea27d678f557570c12145dfb54f39f1df033723d128aa4bc30ea23</originalsourceid><addsrcrecordid>eNqFUcuO1DAQtBBoGRY-YSWfEBwC7TiJnRNCKx4rrcQBOFuedkdrSOxgO4uGn-CXSWZGe-VgteWuqnZXMXYl4I0A0b39ClDXlWxU90rL1xpq3VbdI7YT0Kuq01I-ZrsHyFP2LOcfANA3ABfsotONVrXesb83ARPZTI5nSsvE45xj8MgtFn_vy4Hb4NZT_D66A8cYkEJJtvgYuA98Xm_rQ-a_fbnj2ePPkTjSOHLn86bL7VAo8TnQMkWMiHbkcxwP2SLe2eQdcT9NS_B_jprP2ZPBjplenOsl-_7xw7frz9Xtl0831-9vK5QdlKrudS9V1w5OkK2V65Qe2la1ClDUomndsG-bQfaDcANIqWrpRK2tbfYoYWXIS_bypDun-GuhXMzk8_ZvGygu2WiQTQ_QrcD2BMQUc040mDn5yaaDEWC2IMwxCLO5bLQ0xyDMxrs6D1j2E7kH1tn5tf_u1Kd1y3tPyWRcnURyPhEW46L_z4R_G4ab3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80349006</pqid></control><display><type>article</type><title>Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Chudwin, David S. ; Wara, Diane W. ; Matthay, Katherine K. ; Caulfield, Mary H. ; Schiffman, Gerald ; Mentzer, William C. ; Ammann, Arthur J.</creator><creatorcontrib>Chudwin, David S. ; Wara, Diane W. ; Matthay, Katherine K. ; Caulfield, Mary H. ; Schiffman, Gerald ; Mentzer, William C. ; Ammann, Arthur J.</creatorcontrib><description>Opsonic defects have been reported in unimmunized patients with sickle cell disease. We found significant increases (P&lt;0.001) in serum opsonic activity, measured by a radiolabeled bacterial uptake assay, and in type 7 pneumococcal polysaccharide antibody concentration in 17 such patients 2 years of age or older after pneumococcal polysaccharide immunization. All 17 patients and six healthy controls achieved a type 7 antibody concentration of more than 300 ng antibody nitrogen per milliliter, believed to the protective level of antibody in vivo. Six patients with sickle cell disease less than 2 years of age did not have a significant increase in type 7 antibody concentration after immunization. Only three of these six patients achieved a postimmunization type 7 antibody concentration exceeding 300 ng Ab N/ml. Overall, 16 of 23 patients with sickle cell disease (70%) had a twofold or greater increase in type 7 antibody concentration, and 13 of these (81%) had a corresponding increase in opsonic activity (P&lt;0.001). Thus most patients who responded to pneumococcal polysaccharide immunization had a concurrent increase in opsonic activity in vitro.</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/S0022-3476(83)80285-6</identifier><identifier>PMID: 6848728</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adolescent ; Age Factors ; Anemia, Sickle Cell - complications ; Anemia, Sickle Cell - immunology ; Antibodies, Bacterial - immunology ; Bacterial Vaccines - administration &amp; dosage ; Child ; Child, Preschool ; Female ; Humans ; Immunization ; Infant ; Male ; Opsonin Proteins - immunology ; Pneumococcal Infections - prevention &amp; control ; Pneumococcal Vaccines ; Streptococcus pneumoniae - immunology</subject><ispartof>The Journal of pediatrics, 1983, Vol.102 (1), p.51-54</ispartof><rights>1982 The C. V. Mosby Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-29893765fd1ea27d678f557570c12145dfb54f39f1df033723d128aa4bc30ea23</citedby><cites>FETCH-LOGICAL-c360t-29893765fd1ea27d678f557570c12145dfb54f39f1df033723d128aa4bc30ea23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022347683802856$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6848728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chudwin, David S.</creatorcontrib><creatorcontrib>Wara, Diane W.</creatorcontrib><creatorcontrib>Matthay, Katherine K.</creatorcontrib><creatorcontrib>Caulfield, Mary H.</creatorcontrib><creatorcontrib>Schiffman, Gerald</creatorcontrib><creatorcontrib>Mentzer, William C.</creatorcontrib><creatorcontrib>Ammann, Arthur J.</creatorcontrib><title>Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Opsonic defects have been reported in unimmunized patients with sickle cell disease. We found significant increases (P&lt;0.001) in serum opsonic activity, measured by a radiolabeled bacterial uptake assay, and in type 7 pneumococcal polysaccharide antibody concentration in 17 such patients 2 years of age or older after pneumococcal polysaccharide immunization. All 17 patients and six healthy controls achieved a type 7 antibody concentration of more than 300 ng antibody nitrogen per milliliter, believed to the protective level of antibody in vivo. Six patients with sickle cell disease less than 2 years of age did not have a significant increase in type 7 antibody concentration after immunization. Only three of these six patients achieved a postimmunization type 7 antibody concentration exceeding 300 ng Ab N/ml. Overall, 16 of 23 patients with sickle cell disease (70%) had a twofold or greater increase in type 7 antibody concentration, and 13 of these (81%) had a corresponding increase in opsonic activity (P&lt;0.001). Thus most patients who responded to pneumococcal polysaccharide immunization had a concurrent increase in opsonic activity in vitro.</description><subject>Adolescent</subject><subject>Age Factors</subject><subject>Anemia, Sickle Cell - complications</subject><subject>Anemia, Sickle Cell - immunology</subject><subject>Antibodies, Bacterial - immunology</subject><subject>Bacterial Vaccines - administration &amp; dosage</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infant</subject><subject>Male</subject><subject>Opsonin Proteins - immunology</subject><subject>Pneumococcal Infections - prevention &amp; control</subject><subject>Pneumococcal Vaccines</subject><subject>Streptococcus pneumoniae - immunology</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUcuO1DAQtBBoGRY-YSWfEBwC7TiJnRNCKx4rrcQBOFuedkdrSOxgO4uGn-CXSWZGe-VgteWuqnZXMXYl4I0A0b39ClDXlWxU90rL1xpq3VbdI7YT0Kuq01I-ZrsHyFP2LOcfANA3ABfsotONVrXesb83ARPZTI5nSsvE45xj8MgtFn_vy4Hb4NZT_D66A8cYkEJJtvgYuA98Xm_rQ-a_fbnj2ePPkTjSOHLn86bL7VAo8TnQMkWMiHbkcxwP2SLe2eQdcT9NS_B_jprP2ZPBjplenOsl-_7xw7frz9Xtl0831-9vK5QdlKrudS9V1w5OkK2V65Qe2la1ClDUomndsG-bQfaDcANIqWrpRK2tbfYoYWXIS_bypDun-GuhXMzk8_ZvGygu2WiQTQ_QrcD2BMQUc040mDn5yaaDEWC2IMwxCLO5bLQ0xyDMxrs6D1j2E7kH1tn5tf_u1Kd1y3tPyWRcnURyPhEW46L_z4R_G4ab3Q</recordid><startdate>1983</startdate><enddate>1983</enddate><creator>Chudwin, David S.</creator><creator>Wara, Diane W.</creator><creator>Matthay, Katherine K.</creator><creator>Caulfield, Mary H.</creator><creator>Schiffman, Gerald</creator><creator>Mentzer, William C.</creator><creator>Ammann, Arthur J.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1983</creationdate><title>Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization</title><author>Chudwin, David S. ; Wara, Diane W. ; Matthay, Katherine K. ; Caulfield, Mary H. ; Schiffman, Gerald ; Mentzer, William C. ; Ammann, Arthur J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-29893765fd1ea27d678f557570c12145dfb54f39f1df033723d128aa4bc30ea23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Adolescent</topic><topic>Age Factors</topic><topic>Anemia, Sickle Cell - complications</topic><topic>Anemia, Sickle Cell - immunology</topic><topic>Antibodies, Bacterial - immunology</topic><topic>Bacterial Vaccines - administration &amp; dosage</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infant</topic><topic>Male</topic><topic>Opsonin Proteins - immunology</topic><topic>Pneumococcal Infections - prevention &amp; control</topic><topic>Pneumococcal Vaccines</topic><topic>Streptococcus pneumoniae - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chudwin, David S.</creatorcontrib><creatorcontrib>Wara, Diane W.</creatorcontrib><creatorcontrib>Matthay, Katherine K.</creatorcontrib><creatorcontrib>Caulfield, Mary H.</creatorcontrib><creatorcontrib>Schiffman, Gerald</creatorcontrib><creatorcontrib>Mentzer, William C.</creatorcontrib><creatorcontrib>Ammann, Arthur J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chudwin, David S.</au><au>Wara, Diane W.</au><au>Matthay, Katherine K.</au><au>Caulfield, Mary H.</au><au>Schiffman, Gerald</au><au>Mentzer, William C.</au><au>Ammann, Arthur J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>1983</date><risdate>1983</risdate><volume>102</volume><issue>1</issue><spage>51</spage><epage>54</epage><pages>51-54</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><abstract>Opsonic defects have been reported in unimmunized patients with sickle cell disease. We found significant increases (P&lt;0.001) in serum opsonic activity, measured by a radiolabeled bacterial uptake assay, and in type 7 pneumococcal polysaccharide antibody concentration in 17 such patients 2 years of age or older after pneumococcal polysaccharide immunization. All 17 patients and six healthy controls achieved a type 7 antibody concentration of more than 300 ng antibody nitrogen per milliliter, believed to the protective level of antibody in vivo. Six patients with sickle cell disease less than 2 years of age did not have a significant increase in type 7 antibody concentration after immunization. Only three of these six patients achieved a postimmunization type 7 antibody concentration exceeding 300 ng Ab N/ml. Overall, 16 of 23 patients with sickle cell disease (70%) had a twofold or greater increase in type 7 antibody concentration, and 13 of these (81%) had a corresponding increase in opsonic activity (P&lt;0.001). Thus most patients who responded to pneumococcal polysaccharide immunization had a concurrent increase in opsonic activity in vitro.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>6848728</pmid><doi>10.1016/S0022-3476(83)80285-6</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 1983, Vol.102 (1), p.51-54
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_80349006
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Age Factors
Anemia, Sickle Cell - complications
Anemia, Sickle Cell - immunology
Antibodies, Bacterial - immunology
Bacterial Vaccines - administration & dosage
Child
Child, Preschool
Female
Humans
Immunization
Infant
Male
Opsonin Proteins - immunology
Pneumococcal Infections - prevention & control
Pneumococcal Vaccines
Streptococcus pneumoniae - immunology
title Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T09%3A41%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20serum%20opsonic%20activity%20and%20antibody%20concentration%20in%20patients%20with%20sickle%20cell%20disease%20after%20pneumococcal%20polysaccharide%20immunization&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Chudwin,%20David%20S.&rft.date=1983&rft.volume=102&rft.issue=1&rft.spage=51&rft.epage=54&rft.pages=51-54&rft.issn=0022-3476&rft.eissn=1097-6833&rft_id=info:doi/10.1016/S0022-3476(83)80285-6&rft_dat=%3Cproquest_cross%3E80349006%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80349006&rft_id=info:pmid/6848728&rft_els_id=S0022347683802856&rfr_iscdi=true